featured
Neurological, Psychiatric, and Sleep Investigations After Treatment of Anti-LGI1 Encephalitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study
Lancet Neurol 2024 Mar 01;23(3)256-266, A Muñoz-Lopetegi, M Guasp, L Prades, E Martínez-Hernández, M Rosa-Justícia, V Patricio, T Armangué, L Rami, R Borràs, J Castro-Fornieles, A Compte, C Gaig, J Santamaria, J DalmauFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.